Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Does anthrax antitoxin therapy have a role in the treatment of inhalational anthrax?

Vietri NJ.

Curr Opin Infect Dis. 2018 Jun;31(3):257-262. doi: 10.1097/QCO.0000000000000446. Review.

PMID:
29570493
2.

A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.

Chance T, Chua J, Toothman RG, Ladner JT, Nuss JE, Raymond JL, Biot FV, Demons S, Miller L, Halasohoris S, Mou S, Koroleva G, Lovett S, Palacios G, Vietri NJ, Worsham PL, Cote CK, Kijek TM, Bozue JA.

PLoS One. 2017 Mar 22;12(3):e0174106. doi: 10.1371/journal.pone.0174106. eCollection 2017.

3.

Disrupting the luxS quorum sensing gene does not significantly affect Bacillus anthracis virulence in mice or guinea pigs.

Bozue J, Powell BS, Cote CK, Moody KL, Gelhaus HC, Vietri NJ, Rozak DA.

Virulence. 2012 Oct 1;3(6):504-9. doi: 10.4161/viru.21934. Epub 2012 Oct 1.

4.

Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys.

Chabot DJ, Joyce J, Caulfield M, Cook J, Hepler R, Wang S, Vietri NJ, Ruthel G, Shoop W, Pitt L, Leffel E, Ribot W, Friedlander AM.

Vaccine. 2012 Jan 20;30(5):846-52. doi: 10.1016/j.vaccine.2011.12.010. Epub 2011 Dec 13.

PMID:
22172509
5.

A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics.

Vietri NJ, Purcell BK, Tobery SA, Rasmussen SL, Leffel EK, Twenhafel NA, Ivins BE, Kellogg MD, Webster WM, Wright ME, Friedlander AM.

J Infect Dis. 2009 Feb 1;199(3):336-41. doi: 10.1086/596063.

PMID:
19099484
6.

Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Scorpio A, Chabot DJ, Day WA, O'brien DK, Vietri NJ, Itoh Y, Mohamadzadeh M, Friedlander AM.

Antimicrob Agents Chemother. 2007 Jan;51(1):215-22. Epub 2006 Oct 30.

7.

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.

Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7813-6. Epub 2006 May 3.

8.

The effect of moving to a new hospital facility on the prevalence of methicillin-resistant Staphylococcus aureus.

Vietri NJ, Dooley DP, Davis CE Jr, Longfield JN, Meier PA, Whelen AC.

Am J Infect Control. 2004 Aug;32(5):262-7.

PMID:
15292889
9.

Esophageal ulceration due to cytomegalovirus infection in a patient with acute retroviral syndrome.

Vietri NJ, Skidmore PJ, Dooley DP.

Clin Infect Dis. 2002 Jan 1;34(1):E14-5. Epub 2001 Nov 19.

PMID:
11731967
10.

Supplemental Content

Loading ...
Support Center